Eyal Talor - 14 Aug 2026 Form 4 Insider Report for CEL SCI CORP (CVM)

Reporting relationship
Chief Scientific Officer
Issuer ticker
CVM
Reported as of
14 Aug 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Aug 2026, 09:27:11 UTC
Prior SEC filing
01 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Eyal Talor

Key filing fact

Eyal Talor filed Form 4 for CEL SCI CORP (CVM) on 17 Aug 2026.

Key facts

  • This page summarizes Eyal Talor's Form 4 filing for CEL SCI CORP (CVM).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 17 Aug 2026, 09:27.

Change

  • Previous filing in this sequence was filed on 01 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001238028 Primary reporting owner

TALOR EYAL

Relationship
Chief Scientific Officer
Address
8229 BOONE BLVD, STE 802, VIENNA
Signature
Eyal Talor
Signature date
17 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVM transaction Derivative

Options

Award

Transaction value
Shares
+250,000
Change %
+306%
Price
$0.0100*
Shares after
331,625
Date
14 Aug 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
250,000
Exercise price
$1.49
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options vest in three (3) equal annual installments commencing one year after the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .